✦ LIBER ✦

Change of left ventricular geometric pattern after 1 year of antihypertensive treatment: The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

✍ Scribed by Kristian Wachtell; Björn Dahlöf; Jens Rokkedal; Vasilious Papademetriou; Markku S. Nieminen; Gunnar Smith; Eva Gerdts; Kurt Boman; Jonathan N. Bella; Richard B. Devereux

Book ID: 117842948
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 107 KB
Volume: 144
Category: Article
ISSN: 1097-6744
DOI: 10.1067/mhj.2002.126113

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Change in diastolic left ventricular fil

Change in diastolic left ventricular filling after one year of antihypertensive treatment. The losartan intervention for endpoint reduction in hypertension (LIFE) study

✍ K. Wachtell; J.N. Bella; J. Rokkedal 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Change in systolic left ventricular perf

Change in systolic left ventricular performance after 3 years of antihypertensive treatment. The losartan intervention for endpoint (LIFE) study

✍ K. Wachtell; V. Palmieri; M.H. Olsen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 35 KB

Regression of hypertensive left ventricu

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol. The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

✍ R.B. Devereux; B. Dahlof; E. Gerdts 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 31 KB

Crumbling of left ventricular hypertroph

Crumbling of left ventricular hypertrophy as a surrogate end point (the Losartan for Intervention for Endpoint Reduction in Hypertension [life] study)

✍ Franz H Messerli; Mandeep R Mehra 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Body Build and Risk of Cardiovascular Ev

Body Build and Risk of Cardiovascular Events in Hypertension and Left Ventricular Hypertrophy. The LIFE (Losartan Intervention For Endpoint reduction in hypertension) Study

✍ G. de Simone; K. Wachtell; V. Palmieri 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Cost-effectiveness of losartan-based the

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

✍ McInnes, G; Burke, T A; Carides, G 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 120 KB